Who should avoid Tirzepatide: Tirzepatide (Mounjaro, Zepbound) carries similar restrictions and is contraindicated in: Individuals with a personal or family history of MTC Those with MEN 2, due to the same cancer-related concerns People who have experienced severe gastrointestinal issues, such as chronic pancreatitis or gastroparesis Patients with a known hypersensitivity to tirzepatide or any of its components As always, anyone considering these medications should talk with their healthcare provider about their personal health history and risk factors
Slower Metabolism When you lose weight, especially if it happens quickly, your metabolism often slows down
Some people stop taking GLP-1 medications and maintain their results
Others need the full 200mcg range
It is well known that peripheral injection of GLP-1R agonists interacts with the CNS [36,37]
This holistic approach to treatment underscores the importance of addressing both the physical and mental aspects of obesity, paving the way for a more sustainable and fulfilling lifestyle change